DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q2 2021

SEC EDGAR SourceSEC Filings

Top Holdings420 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.2M$380.2M5.0%$43.01+158.99%
10 qtrssince 2019-Q1
Increased
65
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

6.7M$114.1M1.5%$11.91+38.83%
10 qtrssince 2019-Q1
Increased
52

SPRINGWORKS THERAPEUTICS INC

1.4M$113.4M1.5%
8 qtrssince 2019-Q3
Increased
52

NVIDIA CORP

141,290$113M1.5%$19.69+1.50%
7 qtrssince 2019-Q4
Increased
76
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

482,019$109.3M1.4%$182.58+19.34%
10 qtrssince 2019-Q1
Decreased
0

RELAY THERAPEUTICS INC

2.9M$104.4M1.4%$37.49-0.51%
4 qtrssince 2020-Q3
Increased
53

VISA INC-CLASS A SHARES

428,607$100.2M1.3%$207.41+8.40%
3 qtrssince 2020-Q4
Increased
48

CELSIUS HOLDINGS INC

1.3M$99.2M1.3%$10.05+147.17%
5 qtrssince 2020-Q2
Increased
56

EPAM SYSTEMS INC

176,660$90.3M1.2%$337.68+53.76%
10 qtrssince 2019-Q1
Decreased
0

NATERA INC

790,635$89.8M1.2%$34.08+241.45%
9 qtrssince 2019-Q2
Increased
48

CALIX INC

1.8M$86.4M1.1%$28.48+68.45%
4 qtrssince 2020-Q3
Increased
50
JDJD
ADR

JD.COM INC-ADR

1M$80.4M1.1%$72.24+0.18%
6 qtrssince 2020-Q1
Increased
76

ULTRA CLEAN HLDGS INC

1.3M$70.6M0.9%$33.77+59.66%
7 qtrssince 2019-Q4
Increased
43

BOOT BARN HLDGS INC

797,610$67M0.9%$60.84+34.27%
3 qtrssince 2020-Q4
Increased
58
BILIBILI
ADR

BILIBILI INC-SPONSORED ADR

544,793$66.4M0.9%$125.09-86.23%
4 qtrssince 2020-Q3
Increased
67

GROWGENERATION CORP

1.4M$65.3M0.9%$9.89-80.89%
5 qtrssince 2020-Q2
Increased
43
HDBHDB
ADR

HDFC BANK LTD-ADR

886,669$64.8M0.9%$25.85+33.21%
10 qtrssince 2019-Q1
Decreased
0
SESE
ADR

SEA LTD-ADR

233,925$64.2M0.9%$137.67+108.60%
10 qtrssince 2019-Q1
Increased
56

NEBIUS GROUP NV

905,916$64.1M0.8%
10 qtrssince 2019-Q1
Increased
67
DAVADAVA
ADR

ENDAVA PLC

553,121$62.7M0.8%$41.88+176.92%
10 qtrssince 2019-Q1
Increased
46
$7.5B
AUM
420
Positions
Q2 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
-20%Q1'20$3B+37%Q2'20$4.1B+18%Q3'20$4.9B+27%Q4'20$6.2B+10%Q1'21$6.8B+11%Q2'21$7.5B
Activity profile
$ moved · Q2'21
New24%Increased33%Decreased16%Exited28%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q19%1-4Q30%1-2Y20%2Y+31%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $7.5B across 420 positions as of Q2 2021. Top holdings: TSM (5.0%), IBN (1.5%), SWTX (1.5%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q2 2021 Summary

Active quarter - 116 new positions, 130 exits, 134 increased. Top move: NVDA (INCREASED, conviction 76). Portfolio: $7.5B across 420 positions.

Top holdings by portfolio weight

Total AUM$8B
TSM5.04%
IBN1.51%
SWTX1.50%
NVDA1.50%
BABA1.45%
RLAY1.38%
V1.33%
CELH1.31%
EPAM1.20%
NTRA1.19%
Other1.15%

Portfolio allocation by GICS sector

Sectors11
Technology20.70%
Unknown18.23%
Consumer Cyclical15.47%
Healthcare14.84%
Industrials8.95%
Financial Services7.41%
Communication Services6.39%
Basic Materials3.06%
Consumer Defensive2.80%
Energy1.68%
Other0.47%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology, Unknown, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used